No Picture
Trading Ideas

Alibaba's Jack Ma says Singles' Day shopping results miss expectations

Alibaba Group Holding Inc co-founder Jack Ma said on Wednesday results from the Singles’ Day annual online shopping festival had missed the Chinese e-commerce giant’s expectations. Analysts monitor sales on Singles’ Day to gauge consumer sentiment in China. The Chinese shopping festival is held on Nov. 11 and is also referred to as Double Eleven because of the date. …read more […]

No Picture
Trading Ideas

Starbucks China rival Luckin's rapid expansion powers upbeat forecast

Since its launch in 2017, Luckin has not shied away from spending heavily to open stores as part of its stated goal of overtaking Starbucks Corp in China by the end of the year. The company opened about 700 stores in the third quarter, taking its total in China to 3,680, while Seattle-based Starbucks took two decades to reach 4,125. Starbucks is largely credited with making a nation of tea-lovers embrace coffee and Luckin is looking to ride on that through rapid expansion, heavy advertising and promotions. …read more […]

No Picture
Trading Ideas

Alibaba's Jack Ma says Singles' Day shopping results miss expectations

Alibaba Group Holding Inc co-founder Jack Ma said on Wednesday results from the Singles’ Day annual online shopping festival had missed the Chinese e-commerce giant’s expectations. Analysts monitor sales on Singles’ Day to gauge consumer sentiment in China. The Chinese shopping festival is held on Nov. 11 and is also referred to as Double Eleven because of the date. …read more […]

No Picture
Trading Ideas

UPDATE 1-Abbott CEO Miles White to step down next year

Abbott Laboratories Chief Executive Officer Miles White will step down next year after leading the healthcare conglomerate for more than two decades. White, who will remain the executive chairman, will be succeeded by Chief Operating Officer Robert Ford, the company said on Wednesday. White, 64, was instrumental in Abbott’s acquisitions of rivals St. Jude Medical and Alere, as well as the separation of Abbott’s pharmaceutical arm into AbbVie Inc. …read more […]